Titre : San Francisco

San Francisco : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une maladie infectieuse à San Francisco ?

Un diagnostic repose sur des tests de laboratoire et des antécédents médicaux.
Maladies infectieuses Diagnostic médical
#2

Quels tests sont utilisés pour le VIH à San Francisco ?

Les tests de dépistage incluent les tests sanguins et les tests rapides.
VIH Dépistage
#3

Comment évaluer les maladies respiratoires ?

L'évaluation inclut des examens cliniques et des tests de fonction pulmonaire.
Maladies respiratoires Évaluation clinique
#4

Quels outils pour diagnostiquer la tuberculose ?

Les tests cutanés et les radiographies thoraciques sont couramment utilisés.
Tuberculose Diagnostic
#5

Comment diagnostiquer les maladies mentales ?

Un diagnostic repose sur des évaluations psychologiques et des entretiens cliniques.
Maladies mentales Évaluation psychologique

Symptômes 5

#1

Quels sont les symptômes du COVID-19 ?

Les symptômes incluent fièvre, toux, fatigue et perte de goût ou d'odorat.
COVID-19 Symptômes
#2

Comment reconnaître une crise d'asthme ?

Les symptômes incluent essoufflement, sifflements et toux persistante.
Asthme Symptômes
#3

Quels signes d'une infection à VIH ?

Les signes précoces incluent fatigue, fièvre et ganglions lymphatiques enflés.
VIH Infection
#4

Quels symptômes de la tuberculose ?

Les symptômes incluent toux persistante, perte de poids et sueurs nocturnes.
Tuberculose Symptômes
#5

Comment identifier une dépression ?

Les symptômes incluent tristesse persistante, perte d'intérêt et fatigue.
Dépression Symptômes

Prévention 5

#1

Comment prévenir le VIH ?

L'utilisation de préservatifs et le dépistage régulier sont essentiels.
VIH Prévention
#2

Quelles mesures contre le COVID-19 ?

Le port de masques, la distanciation sociale et la vaccination sont recommandés.
COVID-19 Prévention
#3

Comment prévenir les maladies respiratoires ?

Éviter le tabagisme et se faire vacciner contre la grippe aide à prévenir.
Maladies respiratoires Prévention
#4

Quelles stratégies pour prévenir la tuberculose ?

Le dépistage et le traitement préventif des personnes à risque sont cruciaux.
Tuberculose Prévention
#5

Comment prévenir la dépression ?

Maintenir un mode de vie sain et rechercher un soutien social sont bénéfiques.
Dépression Prévention

Traitements 5

#1

Quels traitements pour le VIH ?

Les traitements incluent les antirétroviraux pour contrôler le virus.
VIH Traitement antirétroviral
#2

Comment traiter l'asthme ?

Le traitement comprend des bronchodilatateurs et des corticostéroïdes inhalés.
Asthme Traitement
#3

Quelles options pour la tuberculose ?

Le traitement standard est une combinaison d'antibiotiques sur plusieurs mois.
Tuberculose Antibiotiques
#4

Comment traiter la dépression ?

Les traitements incluent la thérapie, les antidépresseurs et le soutien social.
Dépression Traitement
#5

Quels traitements pour le COVID-19 ?

Les traitements varient de l'oxygénothérapie aux antiviraux selon la gravité.
COVID-19 Traitement

Complications 5

#1

Quelles complications du VIH ?

Les complications incluent les infections opportunistes et certains cancers.
VIH Complications
#2

Quelles complications de l'asthme ?

Les complications peuvent inclure des crises sévères et des hospitalisations.
Asthme Complications
#3

Quelles complications de la tuberculose ?

Les complications incluent des lésions pulmonaires et la dissémination à d'autres organes.
Tuberculose Complications
#4

Quelles complications de la dépression ?

Les complications peuvent inclure l'anxiété, l'isolement social et le suicide.
Dépression Complications
#5

Quelles complications du COVID-19 ?

Les complications peuvent inclure des problèmes respiratoires chroniques et des séquelles neurologiques.
COVID-19 Complications

Facteurs de risque 5

#1

Quels facteurs de risque pour le VIH ?

Les comportements à risque, comme le partage de seringues, augmentent le risque.
VIH Facteurs de risque
#2

Quels facteurs de risque pour l'asthme ?

Les allergies, la pollution et le tabagisme sont des facteurs de risque connus.
Asthme Facteurs de risque
#3

Quels facteurs de risque pour la tuberculose ?

La pauvreté, le surpeuplement et un système immunitaire affaibli augmentent le risque.
Tuberculose Facteurs de risque
#4

Quels facteurs de risque pour la dépression ?

Les antécédents familiaux, le stress et les traumatismes augmentent le risque.
Dépression Facteurs de risque
#5

Quels facteurs de risque pour le COVID-19 ?

L'âge avancé, les maladies chroniques et l'obésité sont des facteurs de risque majeurs.
COVID-19 Facteurs de risque
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "San Francisco : Questions médicales les plus fréquentes", "headline": "San Francisco : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les San Francisco : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-26", "dateModified": "2026-06-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "San Francisco" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Villes", "url": "https://questionsmedicales.fr/mesh/D002947", "about": { "@type": "MedicalCondition", "name": "Villes", "code": { "@type": "MedicalCode", "code": "D002947", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "Z01.433" } } }, "about": { "@type": "MedicalCondition", "name": "San Francisco", "alternateName": "San Francisco", "code": { "@type": "MedicalCode", "code": "D012495", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Willi McFarland", "url": "https://questionsmedicales.fr/author/Willi%20McFarland", "affiliation": { "@type": "Organization", "name": "San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA, 94102-6033, USA. willi.mcfarland@sfdph.org." } }, { "@type": "Person", "name": "Jessica Lin", "url": "https://questionsmedicales.fr/author/Jessica%20Lin", "affiliation": { "@type": "Organization", "name": "San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA, 94102-6033, USA." } }, { "@type": "Person", "name": "Susan Scheer", "url": "https://questionsmedicales.fr/author/Susan%20Scheer", "affiliation": { "@type": "Organization", "name": "Department of Public Health, San Francisco, CA 94102, USA. Electronic address: susan.scheer@sfdph.org." } }, { "@type": "Person", "name": "Desmond Miller", "url": "https://questionsmedicales.fr/author/Desmond%20Miller", "affiliation": { "@type": "Organization", "name": "San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA, 94102-6033, USA." } }, { "@type": "Person", "name": "Dorie E Apollonio", "url": "https://questionsmedicales.fr/author/Dorie%20E%20Apollonio", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Conceptual framework for preterm birth review in San Francisco.", "datePublished": "2024-05-01", "url": "https://questionsmedicales.fr/article/38751590", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1332972" } }, { "@type": "ScholarlyArticle", "name": "Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco.", "datePublished": "2024-05-22", "url": "https://questionsmedicales.fr/article/38776268", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0303403" } }, { "@type": "ScholarlyArticle", "name": "Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco.", "datePublished": "2023-09-11", "url": "https://questionsmedicales.fr/article/37707298", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/QAI.0000000000003237" } }, { "@type": "ScholarlyArticle", "name": "Impact of a high-volume overdose prevention site on social and drug disorder in surrounding areas in San Francisco.", "datePublished": "2023-09-20", "url": "https://questionsmedicales.fr/article/37748424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.drugalcdep.2023.110969" } }, { "@type": "ScholarlyArticle", "name": "The prevalence and correlates of biomarker positive unhealthy alcohol use among women living with and without HIV in San Francisco, California.", "datePublished": "2024-10-04", "url": "https://questionsmedicales.fr/article/39365789", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0308867" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Régions géographiques", "item": "https://questionsmedicales.fr/mesh/D005842" }, { "@type": "ListItem", "position": 3, "name": "Villes", "item": "https://questionsmedicales.fr/mesh/D002947" }, { "@type": "ListItem", "position": 4, "name": "San Francisco", "item": "https://questionsmedicales.fr/mesh/D012495" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : San Francisco - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur San Francisco", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-08-26", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur San Francisco", "description": "Comment diagnostiquer une maladie infectieuse à San Francisco ?\nQuels tests sont utilisés pour le VIH à San Francisco ?\nComment évaluer les maladies respiratoires ?\nQuels outils pour diagnostiquer la tuberculose ?\nComment diagnostiquer les maladies mentales ?", "url": "https://questionsmedicales.fr/mesh/D012495#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur San Francisco", "description": "Quels sont les symptômes du COVID-19 ?\nComment reconnaître une crise d'asthme ?\nQuels signes d'une infection à VIH ?\nQuels symptômes de la tuberculose ?\nComment identifier une dépression ?", "url": "https://questionsmedicales.fr/mesh/D012495#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur San Francisco", "description": "Comment prévenir le VIH ?\nQuelles mesures contre le COVID-19 ?\nComment prévenir les maladies respiratoires ?\nQuelles stratégies pour prévenir la tuberculose ?\nComment prévenir la dépression ?", "url": "https://questionsmedicales.fr/mesh/D012495#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur San Francisco", "description": "Quels traitements pour le VIH ?\nComment traiter l'asthme ?\nQuelles options pour la tuberculose ?\nComment traiter la dépression ?\nQuels traitements pour le COVID-19 ?", "url": "https://questionsmedicales.fr/mesh/D012495#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur San Francisco", "description": "Quelles complications du VIH ?\nQuelles complications de l'asthme ?\nQuelles complications de la tuberculose ?\nQuelles complications de la dépression ?\nQuelles complications du COVID-19 ?", "url": "https://questionsmedicales.fr/mesh/D012495#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur San Francisco", "description": "Quels facteurs de risque pour le VIH ?\nQuels facteurs de risque pour l'asthme ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour la dépression ?\nQuels facteurs de risque pour le COVID-19 ?", "url": "https://questionsmedicales.fr/mesh/D012495#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie infectieuse à San Francisco ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des tests de laboratoire et des antécédents médicaux." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le VIH à San Francisco ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de dépistage incluent les tests sanguins et les tests rapides." } }, { "@type": "Question", "name": "Comment évaluer les maladies respiratoires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation inclut des examens cliniques et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Quels outils pour diagnostiquer la tuberculose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tests cutanés et les radiographies thoraciques sont couramment utilisés." } }, { "@type": "Question", "name": "Comment diagnostiquer les maladies mentales ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur des évaluations psychologiques et des entretiens cliniques." } }, { "@type": "Question", "name": "Quels sont les symptômes du COVID-19 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, fatigue et perte de goût ou d'odorat." } }, { "@type": "Question", "name": "Comment reconnaître une crise d'asthme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent essoufflement, sifflements et toux persistante." } }, { "@type": "Question", "name": "Quels signes d'une infection à VIH ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes précoces incluent fatigue, fièvre et ganglions lymphatiques enflés." } }, { "@type": "Question", "name": "Quels symptômes de la tuberculose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux persistante, perte de poids et sueurs nocturnes." } }, { "@type": "Question", "name": "Comment identifier une dépression ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent tristesse persistante, perte d'intérêt et fatigue." } }, { "@type": "Question", "name": "Comment prévenir le VIH ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation de préservatifs et le dépistage régulier sont essentiels." } }, { "@type": "Question", "name": "Quelles mesures contre le COVID-19 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le port de masques, la distanciation sociale et la vaccination sont recommandés." } }, { "@type": "Question", "name": "Comment prévenir les maladies respiratoires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et se faire vacciner contre la grippe aide à prévenir." } }, { "@type": "Question", "name": "Quelles stratégies pour prévenir la tuberculose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Le dépistage et le traitement préventif des personnes à risque sont cruciaux." } }, { "@type": "Question", "name": "Comment prévenir la dépression ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain et rechercher un soutien social sont bénéfiques." } }, { "@type": "Question", "name": "Quels traitements pour le VIH ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les antirétroviraux pour contrôler le virus." } }, { "@type": "Question", "name": "Comment traiter l'asthme ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend des bronchodilatateurs et des corticostéroïdes inhalés." } }, { "@type": "Question", "name": "Quelles options pour la tuberculose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard est une combinaison d'antibiotiques sur plusieurs mois." } }, { "@type": "Question", "name": "Comment traiter la dépression ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie, les antidépresseurs et le soutien social." } }, { "@type": "Question", "name": "Quels traitements pour le COVID-19 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements varient de l'oxygénothérapie aux antiviraux selon la gravité." } }, { "@type": "Question", "name": "Quelles complications du VIH ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les infections opportunistes et certains cancers." } }, { "@type": "Question", "name": "Quelles complications de l'asthme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des crises sévères et des hospitalisations." } }, { "@type": "Question", "name": "Quelles complications de la tuberculose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des lésions pulmonaires et la dissémination à d'autres organes." } }, { "@type": "Question", "name": "Quelles complications de la dépression ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure l'anxiété, l'isolement social et le suicide." } }, { "@type": "Question", "name": "Quelles complications du COVID-19 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des problèmes respiratoires chroniques et des séquelles neurologiques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le VIH ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les comportements à risque, comme le partage de seringues, augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour l'asthme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les allergies, la pollution et le tabagisme sont des facteurs de risque connus." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la tuberculose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La pauvreté, le surpeuplement et un système immunitaire affaibli augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dépression ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, le stress et les traumatismes augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le COVID-19 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et l'obésité sont des facteurs de risque majeurs." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 14/06/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Willi McFarland

11 publications dans cette catégorie

Affiliations :
  • San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA, 94102-6033, USA. willi.mcfarland@sfdph.org.

Jessica Lin

5 publications dans cette catégorie

Affiliations :
  • San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA, 94102-6033, USA.

Susan Scheer

5 publications dans cette catégorie

Affiliations :
  • Department of Public Health, San Francisco, CA 94102, USA. Electronic address: susan.scheer@sfdph.org.
Publications dans "San Francisco" :

Desmond Miller

4 publications dans cette catégorie

Affiliations :
  • San Francisco Department of Public Health, 25 Van Ness Avenue, Suite 710, San Francisco, CA, 94102-6033, USA.

Dorie E Apollonio

3 publications dans cette catégorie

Publications dans "San Francisco" :

Danielle Veloso

3 publications dans cette catégorie

Affiliations :
  • San Francisco Department of Public Health.

Caroline Cawley

3 publications dans cette catégorie

Affiliations :
  • University of California, San Francisco, Department of Emergency Medicine, San Francisco, California, USA.
Publications dans "San Francisco" :

Margot Kushel

3 publications dans cette catégorie

Affiliations :
  • University of California, San Francisco, UCSF Center for Vulnerable Populations, San Francisco, California, USA.
Publications dans "San Francisco" :

Phillip O Coffin

3 publications dans cette catégorie

Affiliations :
  • Population Health Division, San Francisco Department of Public Health, Community Health Equity & Promotion Branch, San Francisco, CA, USA.
Publications dans "San Francisco" :

Erin C Wilson

3 publications dans cette catégorie

Affiliations :
  • Center for Public Health Research, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.

Janice K Louie

3 publications dans cette catégorie

Affiliations :
  • Division of Population Health, San Francisco Department of Public Health, San Francisco, California, USA.
  • Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
Publications dans "San Francisco" :

Rocio Agraz-Lara

3 publications dans cette catégorie

Affiliations :
  • Division of Population Health, San Francisco Department of Public Health, San Francisco, California, USA.
Publications dans "San Francisco" :

Maria C Raven

3 publications dans cette catégorie

Affiliations :
  • University of California, San Francisco, Department of Emergency Medicine, San Francisco, California.

Rachel Morello-Frosch

3 publications dans cette catégorie

Affiliations :
  • Department of Environmental Science, Policy and Management, University of California, Berkeley, Berkeley, California 94720, United States.
  • School of Public Health, University of California, Berkeley, Berkeley, California 94720, United States.

Rebecca Sutton

3 publications dans cette catégorie

Affiliations :
  • San Francisco Estuary Institute, 4911 Central Avenue, Richmond, CA 94804, USA. Electronic address: rebeccas@sfei.org.

Lindsie M McCabe

2 publications dans cette catégorie

Affiliations :
  • Department of Biological Sciences, Northern Arizona University, Flagstaff, United States of America Department of Biological Sciences, Northern Arizona University Flagstaff United States of America.

Paige R Chesshire

2 publications dans cette catégorie

Affiliations :
  • Department of Biological Sciences, Northern Arizona University, Flagstaff, United States of America Department of Biological Sciences, Northern Arizona University Flagstaff United States of America.

Neil S Cobb

2 publications dans cette catégorie

Affiliations :
  • Department of Biological Sciences, Northern Arizona University, Flagstaff, United States of America Department of Biological Sciences, Northern Arizona University Flagstaff United States of America.

Susan P Buchbinder

2 publications dans cette catégorie

Affiliations :
  • Bridge HIV, San Francisco Department of Public Health, San Francisco, CA.
  • Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
  • Zuckerberg San Francisco General Hospital, San Francisco, CA.
Publications dans "San Francisco" :

Diane V Havlir

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Zuckerberg San Francisco General Hospital, San Francisco, CA.
Publications dans "San Francisco" :

Sources (296 au total)

Innovation and adaptation: The rise of a fentanyl smoking culture in San Francisco.

Illicitly manufactured fentanyls and stimulants are implicated in the escalating US mortality from drug overdose. San Francisco, California (SF) has seen declining fentanyl injection while smoking has... The study used rapid ethnography to explore fentanyl and methamphetamine use in SF. The team conducted semi-structured interviews (n = 34) with participants recruited from syringe service programs. Vi... Difficulty injecting and fear of overdose motivated transitions from injecting to smoking. Fentanyl was extremely cheap-$10/gram-with variability in quality. Foil was the most commonly used smoking ma... Our data highlight fentanyl residue as a new overdose risk with potential mismatch between the potency of the residual drug and the recipient's tolerance. Further, large doses of fentanyl are being co...

Trends in Time Spent Viremic Among Persons Newly Diagnosed With HIV in San Francisco.

To examine trends in time spent viremic and initiation into antiretroviral treatment (ART) among persons newly diagnosed with HIV in San Francisco.... Using HIV surveillance data, we included persons diagnosed with HIV during 2012-2020, a San Francisco resident at HIV diagnosis, alive 12 months after HIV diagnosis, and had ≥2 viral load tests within... Of 2471 new HIV diagnoses in San Francisco from 2012 to 2020, 1921 (72%) were included. Newly diagnosed persons spent a mean of 40.4% pPT >200, 32.4% pPT >1,500%, and 23.4% pPT >10,000 copies per mill... Percent time spent above each viremic level decreased significantly, whereas rapid ART initiation increased among newly diagnosed persons from 2014 through 2020 compared with 2012-2013. Population dif...

Impact of a high-volume overdose prevention site on social and drug disorder in surrounding areas in San Francisco.

Between January and December 2022 a multi-service center incorporating an overdose prevention site (OPS) operated with city government sanction in San Francisco. One concern often expressed about OPS ... We conducted systematic street observation of 10 indicators of drug- and homelessness-related social nuisance in a 500 m radius around the OPS and around a comparison point in the same city before and... Ratio of relative risks of any reported nuisance in the 500 m area surrounding the OPS from pre- to post-intervention to that of the comparison area was 0.69 (95% CI: 0.54, 0.87; p=0.002). The relativ... We found that implementing authorized OPS services in a U.S. city did not increase the prevalence of visible signs of drug use and homelessness in the surrounding area. These findings are similar to t...

Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.

There is limited systematic information available about the perspectives of participants enrolled in intensive combination HIV cure-related trials inclusive of an extended analytical treatment interru... To assess and understand experiences of people with HIV involved in a combination HIV cure-related trial with an extended ATI.... The trial included five interventions and was followed by an ATI lasting up to 52 wk. From 2022 - 2023, we conducted in-depth interviews with study participants following their extended ATIs. Intervie... We interviewed seven participants. The majority were male, White, and non-Hispanic, with a median age of 37 years. Trust in the research team, scientific altruism and hope of becoming a post-intervent... Our findings demonstrate potential improvements for future ATI trial participant experiences, such as more robust resources for psychosocial support and partner protections. Dedicating greater effort ...

Changes in BMI prior to and during the COVID-19 pandemic among children: a retrospective cohort study in San Francisco, CA.

The COVID-19 pandemic led to dramatic changes in the lives of children that impact cardiometabolic health. Cities and counties had varying policies with respect to school closure, recreational program... This was an electronic medical record-based retrospective cohort study. We included 15,401 children, 4-17 years of age at study onset. Our exposure was time into each of three time periods: (1) March ... Mean BMI-z score increased by 0.06 per year in time period 2, the year prior to the pandemic (p < 0.001, 95% CI: 0.04, 0.09), and by 0.12 per year during time period 3, the first 18 months of the pand... Among children in San Francisco, increases in BMI-z score and overweight/obesity were greater during the pandemic compared to prior changes, with the most pronounced increases among younger and public...

Evaluating oxygen monitoring and administration during overdose responses at a sanctioned overdose prevention site in San Francisco, California: A mixed-methods study.

Overdose prevention sites (OPSs) are spaces where individuals can use pre-obtained drugs and trained staff can immediately intervene in the event of an overdose. While some OPSs use a combination of n... We used descriptive statistics to quantify number and type of overdose interventions delivered in 46 weeks of OPS operation in 2022. We used qualitative data from OPS staff interviews to evaluate expe... OPS staff were successful in reversing 100% of overdoses (n = 333) during 46 weeks of operation. Oxygen became available 18 weeks after opening. After oxygen became available (n = 248 overdose inciden... Although the OPS operated temporarily, it offered important insights. Ensuring consistent oxygen supplies, staffing, and removing 911 call requirements after every naloxone administration could improv...

Exposure to Perfluoroalkyl Substances and Associations with Pubertal Onset and Serum Reproductive Hormones in a Longitudinal Study of Young Girls in Greater Cincinnati and the San Francisco Bay Area.

Per- and polyfluoroalkyl substances (PFAS), endocrine disrupting chemicals with worldwide exposure, cause changes in mammary gland development in rodents. A few human studies report delay in pubertal ... In a cohort of Greater Cincinnati (GC) and San Francisco Bay Area (SFBA) girls recruited at 6-8 years of age, clinical examinations were conducted annually or semiannually with sequential Tanner stagi... Median PFOA serum concentrations in GC (... In multivariable Cox proportional hazard models [adjusted for race, body mass index (BMI)], increasing serum log-transformed PFOA was associated with a delay in pubarche [... PFAS may delay pubertal onset through the intervening effects on BMI and reproductive hormones. The decreases in DHEAS and...

Acculturating to multiculturalism: a new dimension of dietary acculturation among Asian American, Native Hawaiian, and Pacific Islander women in the San Francisco Bay Area, USA.

Dietary acculturation is the process by which diet and dietary practises from the environment of origin are retained or changed and/or those prevalent in a new environment are adopted. Despite rapid p... Data were from a 2013-2014 population-based case-control study in the San Francisco Bay Area, U.S. Survey items were adapted from dietary acculturation scales developed for AANHPI populations. Validat... Three dietary patterns were identified: "Asian," "Western," and a distinct "Multicultural" factor. Respondents reporting a high-Asian diet tended to also report smaller social networks, higher levels ... The finding of a distinct "Multicultural" factor beyond the typical "Asian" and "Western" factors may reflect the multidirectional relationships between culture, diet, and dietary behavior, in which o...